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SUMMARY
Molecular and behavioral responses to opioids are
thought to be primarily mediated by neurons,
although there is accumulating evidence that other
cell types play a prominent role in drug addiction.
To investigate cell-type-specific opioid responses,
we performed single-cell RNA sequencing (scRNA-
seq) of the nucleus accumbens of mice following
acute morphine treatment. Differential expression
analysis uncovered unique morphine-dependent
transcriptional responses by oligodendrocytes
and astrocytes. We examined the expression of
selected genes, including Cdkn1a and Sgk1, by
FISH, confirming their induction by morphine in oli-
godendrocytes. Further analysis using RNA-seq of
FACS-purified oligodendrocytes revealed a large
cohort of morphine-regulated genes. The affected
genes are enriched for roles in cellular pathways
intimately linked to oligodendrocyte maturation
and myelination, including the unfolded protein
response. Altogether, our data illuminate the
morphine-dependent transcriptional response by
oligodendrocytes and offer mechanistic insights
into myelination defects associated with opioid
abuse.
INTRODUCTION
Drug addiction is a global health concern associated with consid-
erable adverse impacts. Affected individuals experience severe
physical and emotional hardship, which also takes a toll on their
families and society (Bauer et al., 2015; Dart et al., 2015). The
fiscal consequences in the United States alone have been esti-
mated to exceed $600 billion a year (https://www.drugabuse.
gov/publications/principles-drug-addiction-treatment-research-
based-guide-third-edition/preface). The current epidemic of
prescription opioid abuse has contributed to an alarming rise in
overdosedeath rates (Dart et al., 2015).Opioid-dependent individ-
uals also exhibit increased comorbidity with other psychiatric
disorders, including depression, as well as impaired white matter
integrity and consequent cognitive deficits (Bora et al., 2012; Liu
et al., 2008). Although environmental risk factors contribute to
drug addiction, it is well-established that acute drug exposure
induces gene expression changes in the CNS and that these
changes affect susceptibility to addiction (L€uscher and Malenka,
2011).
All addictive drugs modulate the mesolimbic pathway of the
brain by elevating dopamine levels in the nucleus accumbens
(NAc), a region in the ventral striatum with a central role in pro-
cessingmotivation, reward, aversion, and reinforcement learning
(Volkow and Morales, 2015). Because of this, researchers have
aimed to elucidate the effects of various addictive drugs,
including methamphetamine (Piechota et al., 2010; Zhu et al.,
2015), cocaine (Albertson et al., 2006; Piechota et al., 2010),
and opioids (Albertson et al., 2006; Korostynski et al., 2007; Pie-
chota et al., 2010), on gene expression in the NAc. However,
because the brain is an exceptionally heterogeneous tissue,
previous experiments using bulk tissue preparations could not
confidently ascribe gene expression changes to a certain cell
type, thereby precluding the elucidation of cellular andmolecular
mechanisms of drug abuse. Advances in microfluidics and
sequencing technology make it feasible to analyze thousands
of single-cell transcriptomes in a single experiment. Various
single-cell RNA sequencing (scRNA-seq) platforms have been
developed (Cao et al., 2017; Islam et al., 2014; Klein et al.,
2015; Zheng et al., 2017), enabling the characterization of dozens
of molecularly distinct CNS cell types from multiple regions.
We profiled the gene expression of 23,276 individual cells from
the NAc of mice using Drop-seq (Macosko et al., 2015). Differen-
tial expression analysis uncovered numerous cell-type-specific
changes in gene expression due to acute morphine treatment.
We observed a dramatic morphine-dependent transcriptional
response in oligodendrocytes, which was an unorthodox result
given that no study has described opioid-dependent gene
expression changes unique to oligodendrocytes. We validated
the morphine-dependent and cell-type-specific expression of a
subset of genes by using fluorescence in situ hybridization
(FISH). We also performed bulk RNA sequencing (RNA-seq)
of oligodendrocytes isolated from mock- or morphine-treated
mice, which confirmed a robust transcriptional response to
morphine in these cells. We identified key molecular pathways
modulated by morphine in oligodendrocytes that are likely to
underlie the myelination defects associated with heroin abuse
in human patients.
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RESULTS
Unbiased scRNA-Seq Analysis Identified 18Distinct Cell
Types in the NAc of Mice
The molecular responses to morphine and other drugs of abuse
by the neurons of the NAc have been well studied. However, the
responses by specific neuronal or glial subpopulations have not
been investigated in an unbiased and high-throughput manner.
To address this, we treated mice with morphine or saline as a
mock control and 4 hr later dissected the NAc. We chose 4 hr
because it is the time at which the maximal number and magni-
tude of gene expression changes were observed in previous
studies of the striatal transcriptional response to morphine (Kor-
ostynski et al., 2007; Piechota et al., 2010). A single-cell suspen-
sion was prepared from the dissociated tissue, and Drop-seq
(Macosko et al., 2015) was used to obtain transcriptomes from
23,276 single cells (Figure 1A). We sequenced these cells to an
average depth of 67,000 reads/cell and detected 1,612 mean
genes and 3,228 mean transcripts (Figure S1). Using principal-
component analysis (PCA), graph-based clustering, and dimen-
sionality reduction for 2D visualization through t-distributed sto-
chastic neighbor embedding (t-SNE) (van der Maaten, 2008), we
identified 18 distinct clusters (Figure 1B), all of which were pre-
sent at nearly identical ratios in mock- and morphine-treated
mice and at comparable ratios among biological replicates
(Table S1). Next, we assigned a major CNS cell-type identity to
each cluster (Figure 1B) by cross-referencing genes that were
enriched in specific clusters with published gene expression
datasets (Gokce et al., 2016; Zhang et al., 2014). Many cluster-
enriched genes have been previously identified as markers for
specific cell types (Table S1), and the overall gene expression
profiles of our samples correlate well with bulk RNA-seq (Hodes
et al., 2015) or scRNA-seq (Gokce et al., 2016) analyses of the
striatum (Figure S1). Clusters from mock- and morphine-treated
mice exhibited striking similarities in cell number, number of
genes detected per cell, and expression levels of cluster-
enriched genes (Figure S2), indicating that the overall cell-type
composition of the NAc is unchanged by acute morphine
treatment.
Subclustering of Neurons Enables the Identification of a
Subpopulation of Morphine-Activated MSNs
The NAc is composed of many neuronal subtypes, yet our initial
t-SNE analysis resolved only three neuronal clusters. To increase
Figure 1. Unbiased Single-Cell RNA-Seq Analysis Identified 18 Distinct Cell Types in the Nucleus Accumbens of Mice
(A) Flowchart showing an overview of the single-cell RNA-seq experimental design.
(B) Spectral t-SNE plots of all cells analyzed frommock-treated mice (12,105) or morphine-treated mice (11,171), colored by density clustering and annotated by
cell-type identity. OPC, oligodendrocyte progenitor cell; NSC, neural stem cell; VLMC, vascular and leptomeningeal cell.
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resolution, we re-clustered all cells initially identified as neurons,
revealing 11 clusters (Figure 2A; Table S1). These clusters
directly correspond to the previously identified neuronal sub-
types of the NAc. For example, g-aminobutyric acid-ergic
(GABAergic) D1 and D2 medium spiny neurons (MSNs) are
known to comprise 95% of the neurons in the NAc (Lobo
et al., 2006); accordingly, we found two major populations of
neurons that were enriched for expression of either Drd1a,
Tac1, and Pdyn (D1 MSNs) or Drd2, Penk, and Adora2a (D2
MSNs) (Figure S3; Table S1). Another 2% of the neurons we
identified were GABAergic (Sst+/Npy+) and cholinergic (Chat+/
Slc5a7+) interneurons. The ubiquitous expression of Gad2
(GABA neuron marker) and Ppp1r1b (striatal neuron marker)
and sparse detection of the glutamate neuron-specific gene
Slc17a7 indicate that our dissections of the NAc were highly ac-
curate, containing minimal contamination with adjacent tissues
such as the cortex (Figure S3). Overall, the neuronal subtype di-
versity that we uncovered is highly concordant with previous
studies of cellular diversity in the NAc, including a previously
described single-cell analysis of the striatum (Gokce et al., 2016).
We were intrigued by a cluster of neurons in the center of the
t-SNE plot characterized by high expression of several immedi-
ate early genes (IEGs), such as Fos (c-fos), Junb, Arc, and Nr4a1
(Figure 2; Figure S3). Morphine treatment resulted in a statisti-
cally significant two-fold increase in the proportion of these acti-
vated MSNs (Figure 2B). It has been reported that c-fos protein
expression is upregulated specifically in D1 MSNs upon acute
morphine treatment (Enoksson et al., 2012). Consistent with
this, Drd1a-expressing cells account for the morphine-depen-
dent increase in the proportion of activated MSNs (Figure 2B).
Furthermore, gene set enrichment analysis indicated that genes
enriched in this cluster are associated with several terms related
to opioid addiction, including morphine dependence and opioid-
related disorders (Table S3). Thus, we identified a subpopulation
of neurons displaying a canonical transcriptional response to
acute morphine treatment.
Cell-Type-Specific Differential Expression Analysis
Uncovered a Robust Morphine-Dependent
Transcriptional Response in Oligodendrocytes
The primary goal of this study was to identify cell-type-specific
alterations in gene expression induced by morphine. To accom-
plish this, we used single-cell differential expression (SCDE)
software that uses a Bayesian approach to detect differentially
expressed (DE) genes from single-cell data (Kharchenko et al.,
2014).We presumed thatMSNswould exhibit the strongest tran-
scriptional response, because these cells are known to express
opioid receptors, display an electrophysiological response to
morphine, and mediate morphine-induced behavioral pheno-
types.We found that morphine induces the expression of several
hundred genes, including the classical markers Fos, Junb, and
Nr4a1, in D1 neurons of the activated MSN cluster compared to
other D1 neurons (Table S2).We also detectedmorphine-depen-
dent changes in gene expression in nearly every glial cell type,
with the most numerous changes found in oligodendrocytes
(OLs) (Figure 3). Morphine elicited significant alterations in gene
expression in each of six clusters of OLs (Figure 3B; Figure S4),
which correspond to developmental states in the continuum
from oligodendrocyte progenitor cells (OPCs) to myelin-forming
OLs (MFOLs) and mature OLs (MOLs) (Figure 4A) (Marques
et al., 2016). Many of the morphine-induced genes identified
in MFOLs and MOLs, including Cdkn1a, Phactr3, and serum/
glucocorticoid-regulated kinase 1 (Sgk1), have been previously
reported to be upregulated by morphine in the striatum (Koros-
tynski et al., 2007; Piechota et al., 2010; Skupio et al., 2017),
but these changes could not be confidently ascribed to a specific
Figure 2. Iterative Clustering of Neurons Enables the Identification of a Subpopulation of Morphine-Activated MSNs
(A) Spectral t-SNE plot of 13,033 neurons, annotated by cell-type identity. MSN, medium spiny neuron.
(B) Zoomed view of all-neuron t-SNEwith cells colored by treatment. Bar graph displays the percentage of total neurons in the activatedMSN cluster, stratified by
treatment and expression of the dopamine receptor (D1 versus D2). Error bars show SD among four biological replicates (*p = 0.028, paired t test, two-sided).
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cell type (Figure 4B, bolded genes). 13 of the top 30 morphine-
induced genes in OLs (SCDE p value < 0.0001) are reported tar-
gets of the glucocorticoid receptor (GR) (Figure 4B, marked by
asterisks). GR signaling is known to play a key role in morphine-
dependent gene expression and behaviors in mice (Marinelli
et al., 1998) and was shown to be critical for a large subset of
morphine-induced transcriptional responses in cultured astro-
cytes (Slezak et al., 2013). We found a significant enrichment
of GR targets among morphine-induced genes in astrocytes
but also uncovered a distinct subset of GR target genes in OLs
(Figure 4C; Table S3). Altogether, these data suggest a robust
and previously underappreciated transcriptional response to
morphine in OLs. Because multiple studies suggest myelin pa-
thology in human opioid addicts (Bora et al., 2012; Li et al.,
2016; Liu et al., 2008; Upadhyay et al., 2010; Wang et al., 2011),
we pursued this observation, with the goal of illuminating themo-
lecular mechanisms by which morphine influences OL function.
In Vivo Validation of Cell-Type-Specific Morphine-
Dependent Changes in Gene Expression by FISH
Although single-cell mRNA profiling is widely used for the identi-
fication of new cellular subtypes, calling DE genes from these
data can be challenging due to technical issues such as dropout
and dynamic range compression (Dal Molin et al., 2017). There-
fore, we sought to independently validate some of the most
dramatic morphine-dependent changes in gene expression.
We used FISH to costain Cdkn1a or Sgk1 andMbp (myelin basic
protein), a highly expressed marker of OLs (Figure 5A). The
Cdkn1a and Sgk1 signal was sparsely detected in mock-treated
mice, while morphine treatment elicited a dramatic increase
in puncta number selectively in OLs (Figures 5B–5D). The
morphine-dependent increase was observed throughout the
NAc and dorsal striatum but was especially apparent in oligo-
dendrocyte-dense white matter tracts, such as the anterior
commissure (Figure 5B) and corpus callosum (Figure 5C). This
suggests that theOL response tomorphine is likely not restricted
to the NAc. The anterior commissure was included within our
initial NAc dissections; thus, OL lineage cells from this region
comprise a significant fraction of the total OLs in our scRNA-
seq dataset (roughly 25% based on estimates from the Mbp
FISH signal). When mice were pre-treated with naltrexone
(NTX), an opioid receptor antagonist, the morphine-dependent
induction of Cdkn1a and Sgk1 was dramatically reduced (Fig-
ures 5A–5D), indicating that their induction occurs in an opioid
receptor-dependent manner. As expected, morphine-depen-
dent induction of the immediate-early genes Fos, Junb, and
Nr4a1 was observed in the NAc and dorsal striatum, predomi-
nantly in Drd1-expressing cells (D1 MSNs), and was similarly
reduced by NTX pre-treatment (Figure S5). Altogether, these re-
sults validate the cell-type-specific transcriptional responses we
identified by scRNA-seq and suggest that both neuron- and
OL-specific changes are mediated by opioid receptor activation.
Bulk RNA-Seq of FACS-Isolated OLs Revealed a
Remarkable Extent of Transcriptional Regulation by
Morphine
Because our Drop-seq and FISH data indicated a robust oligo-
dendrocyte transcriptional response to morphine in vivo, we
sought to validate this finding in vitro. We treated purified cul-
tures of mouse OLs with morphine and assessed expression of
Cdkn1a, Sgk1, and Phactr3 by qRT-PCR. Expression of these
genes was not appreciably affected by morphine (Figure S6),
suggesting that the responsewe observed in vivomight bemedi-
ated by an indirect or non-cell-autonomous mechanism. To
further characterize this response, we adapted an immunostain-
ing and fluorescence-activated cell sorting (FACS)-based
approach (Robinson et al., 2014) to isolate OLs from the entire
brains of six mice, three each mock or morphine treated. Saline
or morphine injections and tissue dissociation were performed
exactly as in our scRNA-seq experiments to enable cross-valida-
tion between the two datasets. We gated out CD45+ and
PDGFRa+ populations to remove immune cells and OPCs,
respectively, and then isolated MFOLs and/or MOLs based on
their dual expression of GALC and MOG (Figure S7A). RNA
was purified from each of the six samples and examined by
qRT-PCR.We found 10- to 20-fold enrichment of theOLmarkers
Figure 3. SCDE Analysis Uncovered Cell-Type-Specific Responses
to Morphine
(A and B) We performed single-cell differential expression (SCDE) (morphine
versus mock) on each t-SNE cluster. The total number of unique genes
significantly induced or reduced by morphine is shown, grouped by (A) major
CNS cell type or (B) glial subpopulation. Astrocyte_Vim, Astrocyte_Synaptic,
and Astrocyte_Major refer to three subclusters of astrocytes, and Astrocyte_all
is the combined analysis of all astrocytes. MO_all denotes the combined
analysis of all MFOLs and/or mature oligodendrocytes (e.g., MFOL_1,
MFOL_2, and MOL). See STAR Methods and Table S2 for additional details.
Full terms for abbreviations of oligodendrocyte clusters (red) are given in the
legend of Figure 4.
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Cnp andMog, which was comparable to that observed following
affinity purification of ribosome-associated mRNAs from Cnp-
Cre x HA-Rpl22 (Ribotag) mice (Sanz et al., 2009). A significant
reduction of the neuronal marker Rbfox3/NeuN and the astro-
cytic marker Gfap in these FACS samples indicated enhanced
specificity of this approach compared to the Ribotag method
(Figures S7B and S7C). Assured that this was an enriched OL
population, we tested the morphine-dependent upregulation of
Cdkn1a andSgk1 by qRT-PCR and found that theywere induced
by more than 10-fold (Figure S7C).
To ascertain the full extent of morphine-dependent transcrip-
tional regulation in OLs, we next performed RNA-seq on these
sorted samples. We reasoned that the FACS population should
be most comparable to the three MFOLs and/or MOL clusters
observed in our single-cell transcriptional profiling (MFOL_1,
MFOL_2, and MOL), because these clusters specifically and
ubiquitously express Mog. Differential expression analysis of
the bulk FACS-RNA-seq data confirmed 85.5% (59/69) of the
changes detected by single-cell analysis (SCDE) of OLs. In
addition, we uncovered an additional 935 genes significantly
affected by acute morphine treatment (DESeq adjusted p value
[p-adj] < 0.05 and abs[log2FC] > 0.5) (Figure 6A; Table S5). These
results demonstrate that most morphine-dependent expression
changes detected by single-cell RNA-seq were bona fide; in
addition, our bulk RNA-seq experiments identified a large set
of expression changes that were not observed in our single-
cell experiments, illustrating the increased sensitivity of the
Figure 4. Iterative Clustering and SCDE
Revealed a Robust Morphine-Dependent
Transcriptional Response by Oligodendro-
cytes
(A) Iterative clustering of all 3,817 oligodendro-
cytes (OLs) reveals subpopulations corresponding
to OL maturation state. OPC, oligodendrocyte
progenitor cell; COP, differentiation-committed
OL progenitor; NFOL, newly formed OL; MFOL,
myelin-forming OL; MOL, mature OL.
(B) Morphine robustly modulates the expression of
several genes in OLs. (Left) Heatmap of relative
gene expression for a subset of genes in three
clusters of MFOLs and/or mature OLs. Columns
representing individual cells are ordered horizon-
tally by biological replicate and treatment (red,
mock; blue, morphine). Bolded genes have been
previously reported to be induced by morphine in
the mouse striatum, and those marked with an
asterisk are reported targets of the glucocorticoid
receptor (GR). (Right) SCDE p value and expres-
sion percentages for combined analysis of all
MFOLs and/or mature OLs (MFOL_1, MFOL_2,
and MOL). Expression is defined as detection
of R1 transcript. Dots and error bars are,
respectively, the mean and SD among four bio-
logical replicates.
(C) Morphine regulates the expression of distinct
subsets of GR target genes in OLs and astrocytes.
FACS-RNA-seq approach. Considering
the FACS-RNA-seq dataset as the gold
standard upon which to benchmark sin-
gle-cell DE analysis, we optimized the sensitivity of single-cell
DE calling by filtering out lowly expressed genes (those detected
in less than 2% of cells), removing a fold-change cutoff, and re-
laxing the SCDE p value cutoff. These criteria effectively doubled
the number of DE genes detected in MFOLs and/or MOLs
without compromising specificity (Figure 6B, compare green
dot and red diamond). Of the most significant morphine-regu-
lated genes identified by a previous microarray analysis of the
striatum (Piechota et al., 2010), nearly half of them can be attrib-
uted to OLs (Figure 6C). In addition, our single-cell analysis
allowed us to ascribe other reported morphine-dependent
gene expression changes to neurons or astrocytes (Figure 6C).
A comparison of our data to changes observed at various time
points following acute morphine treatment (1, 2, 4, or 8 hr)
indicates cell-type-specific differences in the temporal response
to morphine (Figure S8). These analyses underscore the
utility of cell-type-specific profiling strategies and suggest
that oligodendrocyte-specific responses to opioids have been
underappreciated.
To obtain biological insights into the response to morphine by
OLs, we performed gene set enrichment and pathway analyses
of our FACS-RNA-seq data. This confirmed the enrichment of
GR targets, including all GR-related genes we identified by
Drop-seq, among the morphine-induced genes in OLs (Fig-
ure S9; Table S3). We also found that several morphine-
repressed genes encode endoplasmic reticulum (ER) chaperone
proteins with critical functions in ER quality control (ERQC) and
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the unfolded protein response (UPR) (Figure 7; Figure S9).
MFOLs are thought to be particularly susceptible to ER stress
because of their high rates of protein and lipid synthesis (Lin
and Popko, 2009). Accordingly, components of theUPRmachin-
ery are dysregulated in various demyelinating diseases of the
peripheral and CNS (Lin and Popko, 2009). The morphine-
dependent downregulation of ERQC and UPR could lead to an
increase in the intracellular accumulation and/or export of mis-
folded proteins, as well as downstream consequences on oligo-
dendrocyte survival, maturation, and/or myelination. This has
considerable clinical implications in light of several studies
describing impaired white matter integrity in the brains of human
opioid users (Bora et al., 2012; Li et al., 2016; Liu et al., 2008;
Upadhyay et al., 2010; Wang et al., 2011).
Figure 5. In Vivo Validation of Oligodendrocyte-Specific Morphine-Dependent Gene Expression by FISH
(A) Schematic of experimental design. Pre-treatment with naltrexone (NTX) should block morphine responses mediated by opioid receptor activation.Mbp in situ
hybridization (ISH) (from the Allen Brain Atlas database) is shown to illustrate regions with high densities of OLs.
(B and C) Expression of Cdkn1a and Sgk1 is induced by morphine in OLs in an opioid receptor-dependent manner. Representative images of the anterior
commissure (B) and corpus callosum (C) are shown. Signals are pseudocolored by expression of Cdkn1a (green), Sgk1 (green), Mbp (magenta), and/or DAPI
(blue). Scale bars, 100 mm (left panels) and 20 mm (right panels and zoomed view).
(D) Quantification of the percentage of OLs (left panel: n = 781 cells; right panel: n = 1,374 cells) or of non-OLs (middle panel: n = 1,000 cells) withR5 puncta of
Cdkn1a or Sgk1 (3 mice per condition; paired t test, two-sided; NS, not significant; **p < 1e4, *p < 0.05).
(E) t-SNE plots of all cells from mock- or morphine-treated mice overlaid with expression of Cdkn1a or Sgk1 indicates that the morphine-dependent induction of
these genes occurs predominantly in OLs. In the case of Cdkn1a, a modest induction was also detected in astrocytes and endothelial cells.
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DISCUSSION
Molecular and behavioral responses to opioids have long been
presumed to be mediated by neurons. The finding that OLs and
astrocytes express opioid receptors in vitroand in vivo suggested
that they toomight respond toopioids (Knappet al., 1998;Stiene-
Martin et al., 2001). Astrocyte proliferation is reduced by stimula-
tion of mu opioid receptor (MOR), kappa opioid receptor (KOR),
or delta opioid receptor (DOR) (Stiene-Martin and Hauser,
1991; Hauser et al., 1996) and morphine-induced transcriptional
responses of primary astrocytes have been described (Slezak
et al., 2013). MOR agonists enhance proliferation of immature
OLs, but not MOLs (Knapp and Hauser, 1996), while KOR ago-
nists appear to promote OL differentiation and myelination
(Knapp et al., 1998; Mei et al., 2016; Du et al., 2016). Altogether,
previous reports indicate that opioids differentially influence the
survival, proliferation, and/or differentiation of OLs and astro-
cytes, but themolecular mechanisms remain poorly understood.
Brain imaging of heroin users has revealed impaired whitematter
integrity, implicatingOLs in the pathophysiology of opioid depen-
dence (Bora et al., 2012; Li et al., 2016; Liu et al., 2008; Upadhyay
et al., 2010;Wang et al., 2011). Heroin abuse has also been linked
to leukoencephalopathies that are likely mediated by OL
dysfunction (Bach et al., 2012). We performed unbiased profiling
of cell-type-specific transcriptional responses to morphine and
uncovered a remarkable number of alterations in gene expres-
sion that are unique to OLs. Many of the gene expression
changes we observed in OLs are also altered following chronic
opioid morphine exposure (Skupio et al., 2017). Our results are
consistent with previous reports suggesting a role for opioid
signaling in OL maturation and myelination. Moreover, our
detailed characterization of the OL-specific response to
morphine offers insights into the putative mechanisms of OL
dysfunction in opioid-induced myelin pathology.
The most significantly DE gene we detected in OLs is Cdkn1a,
which encodes p21. The major function of p21 is the inhibition of
cyclin-dependent kinases that leads to cell-cycle arrest. In OLs,
its expression is required for differentiation and myelination (Ze-
zula et al., 2001). It has been demonstrated that autonomous
transforming growth factor b (TGF-b) signaling drives oligoden-
drocyte differentiation and CNS myelination during postnatal
development via SMAD3/4-dependent transcriptional activation
of Cdkn1a and repression of Myc (c-myc) (Palazuelos et al.,
2014). We observed morphine-dependent reduction in the
Figure 6. Bulk RNA-Seq of FACS-Isolated OLs Revealed a Remarkable Extent of Transcriptional Regulation by Morphine
(A) Venn diagram illustrating significant overlap between DE genes identified from Drop-seq (OLs) or FACS-RNA-seq.
(B) We improved the sensitivity of single-cell DE analysis with minimal loss in specificity. The number of DE genes (true positives: present in the FACS-RNA-seq
top 1,000 list) detected by SCDE of OLs was plotted versus the empirical false discovery rate (FDR; STAR Methods). We optimized SCDE by filtering out genes
expressed in less than 2% of cells, removing a fold-change cutoff, and relaxing the p value cutoff to 0.13 (green circle).
(C) Left column of the heatmap shows the relativemorphine-dependent induction (log2FCmorphine versus saline: 4 hr) of a subset of genes previously reported to
be induced by morphine, as assessed by microarray of total striatum (Piechota et al., 2010). We filtered the top 100 morphine-regulated genes from that dataset
for those significantly affected in OLs (FACS-RNA-seq and/or Drop-seq),Drd1a-expressing activatedMSNs (D1 Act. MSNs), or astrocytes to obtain the 60 genes
shown here. Opaque blocks (labeled NS) indicate changes that were not statistically significant (p < 0.05).
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OL-specific expression of Myc, as well as Sox2 and Sox10, key
drivers of OPC identity. Sox10 expression is downregulated in
the brains of rats following heroin self-administration (Martin
et al., 2018). Our single-cell analyses revealed that a significant
number of GR-regulated genes are induced by morphine in OLs.
Morphine rapidly increases serum levels of corticosterone
(Simon et al., 1975), which in turn induces expression of Sgk1
(Miyata et al., 2011). GR signaling is critical for morphine-
dependent dopamine release and locomotor activation in mice
(Marinelli et al., 1998), but thecontributions ofOLs to thesepheno-
types have not been examined. Presumably, the morphine-
dependent induction of Sgk1 and a subset of the other genes
we identified occurs via GR-dependent transcriptional activation.
The robust inductionofSgk1weobserved isparticularly intriguing,
because this gene facilitates morphological changes in OLs that
are associated with depressive-like behaviors (Miyata et al.,
2015). Alterations in OL morphology have also been observed
in morphine-treated mice (Hauser et al., 2009). Thus, the
morphine-dependent induction ofSgk1 specifically in OLs consti-
tutes a putative molecular mechanism underlying depressive-like
behaviors in opioid-dependent individuals. It was previously sug-
gested that morphine- and GR-dependent gene expression
changes (including Sgk1 induction) are largely confined to astro-
cytes (Slezak et al., 2013). However, our single-cell analyses indi-
cate that many GR-dependent genes are induced uniquely in
either OLs (i.e., Sgk1 and Sgk3) or astrocytes (i.e., Tsc22d3 and
Gjb6), whereas others are induced in both of these cell types
(i.e., Fkbp5 and Nfkbia). Cell-type-specific expression patterns
of opioid receptor subtypes and GR may explain the shared and
unique gene expression changes we observed in neurons, astro-
cytes, andOLs.Unfortunately, becauseopioid receptor genes are
relatively lowly expressed, theywere only sparsely detected in our
single-cell data, obfuscating our attempts to correlate patterns of
opioid receptor expression with the observed transcriptional
response tomorphine. Regarding themechanismof the response
by OLs, our FISH data suggest that opioid receptor activation is
critical, but the relativecontributionsofOL-,neuron-, and/orastro-
cyte-derived opioid receptors remain unknown. Our in vitro data
indicate that a non-cell-autonomous mechanism is likely, but
they do not exclude the possibility of OL-specific, GR-mediated
effects. We also cannot rule out the putative contributions of
other indirectmechanisms, includingneuronal activity-dependent
responses and paracrine regulation by neurons, astrocytes,
and/or microglia.
Our pathway analysis revealed highly significant morphine-
dependent downregulation of genes encoding heat shock pro-
teins, ER chaperones, and other factors critically involved in
the UPR and ER quality control (ERQC). The expression of heat
shock proteins, including Hsp70 (Hspa1a) and Hsc70 (Hspa8),
has previously been shown to be modulated by morphine treat-
ment of rats (Ammon-Treiber et al., 2004; Salas et al., 2011).
Proper regulation of the UPR is essential for efficient myelination,
as evidenced by the apparent dysregulation of UPR in multiple
myelin disorders, including Charcot-Marie-Tooth disease,
vanishing white matter disease, and multiple sclerosis (Lin and
Popko, 2009; Volpi et al., 2017). Under normal conditions,
GRP78/BiP (encoded by Hspa5) is thought to initiate the UPR
by sensing misfolded proteins in the ER (Volpi et al., 2017),
and its conditional ablation in OLs or Schwann cells results in
cell death and severe hypomyelination (Hussien et al., 2015).
Coincidentally, Hspa5 is also the most significantly morphine-
repressed gene that we detected in OLs. The reduced expres-
sion of downstream response genes, including the anti-survival
gene CHOP (Ddit3) and several ER chaperone proteins, sug-
gests that morphine potently suppresses the canonical UPR,
which normally entails attenuation of global protein synthesis,
degradation of misfolded proteins, and under severe ER stress,
autophagy or apoptosis. Previous studies suggested that peri-
natal exposure to other opioid drugs, specifically buprenorphine
and methadone, appears to promote myelination (Eschenroeder
et al., 2012; Sanchez et al., 2008; Vestal-Laborde et al., 2014).
Perhaps in the context of chronic opioid exposure, persistent
upregulation of myelin synthesis and concomitant downregula-
tion of ERQC leads to increased accumulation and/or export
of misfolded myelin constituents and therefore altered myelin
composition. The integrity and composition of myelin have not
been investigated in models of long-term morphine exposure.
In summary, we used scRNA-seq to enable the elucidation of
cell-type-specific responses to morphine in the NAc of mice. We
identified a dramatic transcriptional response by OLs and shed
Figure 7. Several Components of the UPR Are Downregulated by
Morphine in OLs
Genes downregulated by morphine in OLs (p-adj < 1e8, log2FC < 0.5) are
shown in orange, and unaffected factors are shown in gray. The expression
of Xbp1 (XBP-1), as well as numerous XBP-1-induced genes (shown in the
orange box), are reduced by morphine, as are several endoplasmic
reticulum (ER) chaperone proteins involved in ER quality control (ERQC).
These chaperones assist in the proper folding and export of proteins or target
misfolded proteins to the proteasome by a process known as ER-associated
degradation (ERAD). The downregulation of these factors might lead to the
increased accumulation and/or export of misfolded proteins, including myelin
constituents.
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light on the underlying molecular mechanisms of this response,
specifically implicating GR signaling and the UPR as potential
links between gene expression changes we observed and
opioid-mediated myelin pathology. Our single-cell and bulk
RNA-seq datasets should serve as valuable resources for
research aiming to assess transcriptional responses to opioids
or other drugs of abuse. Future studies are necessary to investi-
gate the mechanisms, functional consequences, and physiolog-
ical significance of oligodendrocyte-opioid interactions.
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Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, Robi Mitra
(rmitra@wustl.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
All animal care and experimental procedures were approved in advance by the National Institute of Health andWashington University
School of Medicine Institutional Animal Care and Use Committee (Protocol #20170030). Male C57BL/6 mice (6-12 weeks old) were
used for all experiments, and all animals were socially housed on a 12 h light dark cycle with water and food ad libitum. Mice were
injected with saline or morphine sulfate (20 mg/kg) intraperitoneally, and/or naltrexone hydrochloride (2 mg/kg) subcutaneously.
Cnp-Cre mice were crossed with Rpl22-HA (‘‘RiboTag’’) (Sanz et al., 2009) mice (both in the C57BL/6 background) to generate
Cnp-Cre x RiboTag mice, facilitating the immunoprecipitation of oligodendrocyte-enriched mRNAs for qRT-PCR analysis.
METHOD DETAILS
Dissection and tissue dissociation
Four h after saline (mock) or morphine injection, mice were anesthetized by isoflurane and euthanized by decapitation. Brains were
rapidly extracted, cooled in ice-cold Hibernate A (-Ca) media for 5 min, then placed ventral surface up onto a chilled Petri dish on ice.
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Antibodies
Anti-Mog Millipore Cat# MAB5680; RRID:AB_1587278
Anti-GalC-FITC Millipore Cat# FCMAB312F; RRID:AB_10806360
Anti-PDGFRa-PE BD Biosciences Cat # 562776; RRID:AB_657615
Anti-CD45-Pacific Blue BioLegend Cat# 103126; RRID:AB_493535
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Trehalose Sigma-Aldrich T5251; CAS: 6138-23-4
Neural Tissue Dissociation Kit Miltenyi Biotech 103-092-628
Critical Commercial Assays
Lightning Link Rapid Cy5 Novus Biosciences 342-0010
ViewRNA ISH Cell Assay Thermo Fisher QVC-0001
MiniMACS Separator Miltenyi Biotech 130-042-102
Deposited Data
Raw and analyzed data This paper GSE118918
Experimental Models: Organisms/Strains
C57BL/6 mice (male; 6-12 weeks) Jackson Laboratory N/A
Cnp-Cre mice N/A N/A
Rpl22-HA (Ribotag) mice Sanz et al., 2009 N/A
Cnp-Cre x Ribotag mice This paper N/A
Oligonucleotides
*See Table S4 for list of primers used for qRT-PCR N/A N/A
Software and Algorithms
Seurat Satija et al., 2015 http://satijalab.org/seurat/
Monocle Qiu et al., 2017 http://cole-trapnell-lab.github.io/monocle-release/
SCDE Kharchenko et al., 2014 http://hms-dbmi.github.io/scde/
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The rostral and caudal boundaries of the NAc were visually approximated and a 1 mm-thick coronal section was obtained using a
chilled razor blade. The NAcwasmicrodissected at its dorsolateral borders and pooled by experimental condition (twomice per repli-
cate). Pooled tissue samples were digested in papain/DNase I solution for 1 h at 37C, according to a previously published protocol
(Saxena et al., 2012). The final volume was 1 mL per mouse NAc. Digestion was stopped by dilution with EBSS #2 (Saxena et al.,
2012), which contains ovomucoid protease inhibitor. Tissue was centrifuged at 300g for 5 min, resuspended in EBSS #2, then gently
triturated with a P200 pipette. The resulting cell suspension was divided between two microfuge tubes and diluted with Drop-seq
buffer to a volume of 1 mL per tube (per 2 pooled samples). Drop-seq buffer consisted of 5% (wt/vol) trehalose, Hank’s buffered
salt solution (HBSS;magnesium- and calcium-free), 2.13mMMgCl2, 2mMMgSO4, 1.26mMCaCl2, 1mMglucose and 0.02%bovine
serum albumin. Cells were washed twice by centrifugation at 300g for 5min, followed by resuspension in 1 mL Drop-seq buffer. Cells
were then passed through a 40-mmmesh filter, diluted to 210 cells/mL using cell concentration estimates from a hemocytometer, and
kept on ice until use (< 30 min).
Drop-seq library generation and QC
Drop-seq was performed as previously described (Campbell et al., 2017). Mouse NAc suspensions were processed through Drop-
Seq in eight separate groups over four separate batches (one batch per day). Libraries were sequenced on the Illumina HiSeq3000 or
HiSeq2500. Read 1 was 25 bp (bases 1–12 cell barcode, bases 13–20 UMI – unique molecular identifier), read 2 (paired end) was
75 bp, and the index primer was 7 bp. Raw sequence data were first filtered to remove all read pairs with a barcode base quality
of less than 10. The second read (75 bp) was then trimmed at the 50 end to remove any TSO adaptor sequence and at the 30 end
to remove poly(A) tails of length 6 or greater, then aligned to the mouse (mm10) genome using STAR v2.4.2a with default settings.
Uniquely mapped reads were grouped by cell barcode. A list of UMIs in each gene, within each cell, was assembled, and UMIs within
ED = 1weremerged together. The total number of unique UMI sequences was counted, and this number was reported as the number
of transcripts of that gene for a given cell.
All cell barcodes in which 500 or more genes and 1000 or more transcripts (UMIs) were detected were used in downstream anal-
ysis. Raw digital expression matrices were generated separately, then the replicates from each experimental group were merged
together into a single matrix. Cells with high expression levels of one or more marker gene(s) of more than one cell type (i.e., neuron,
oligodendrocyte, astrocyte, endothelial cell, etc.), representing likely cell doublets/multiplets, were removed (4% of all STAMPS),
resulting in a 12,105-cell barcode dataset for mock treatment and a 11,171-cell barcode dataset for morphine treatment. Gene
expression was normalized in Scater (McCarthy et al., 2017) using the method described by Lun et al. (Lun et al., 2016), and genes
with expression inR 50 cells were retained for clustering. Before clustering, we removed unwanted variation due to number of UMIs,
ratio of reads mapping to mitochondrial genes, and batch effects using Seurat software (Satija et al., 2015).
Unsupervised clustering and dimensionality reduction
We used Seurat to perform clustering (Butler et al., 2018; Satija et al., 2015). We identified genes that were most variable across the
entire dataset, controlling for the known relationship betweenmean expression and variance.We calculated themean and dispersion
(variance/mean) for each gene across all cells, then identified outlier genes. To distinguish principal components (PCs) for further
analysis, we used the PCElbowPlot() function, and found that PCs beyond 15 accounted for negligible variance. We identifiedmolec-
ularly distinct clusters using the FindClusters() function with the Louvain algorithm with multilevel refinement, using a high resolu-
tion (2.0) to detect weakly distinguishable clusters. We then built a classification hierarchy, merged clusters with higher than 0.05
Out-of-bag error (OOBE) from a random forest classifier, and performed t-distributed stochastic neighbor embedding (t-SNE)
(van der Maaten, 2008) in Seurat with default settings. This allowed us to assign cells into a total of 18 cell type clusters each for
mock and morphine. To further resolve cell subtypes, cells corresponding to neuronal, oligodendrocyte, or other clusters were com-
bined, then iteratively clustered as above using CCA (Butler et al., 2018). Altogether, we identified 29molecularly distinct cell types, all
of which were shared between mock- and morphine-treated mice.
scRNA-seq analysis
To analyze differential gene expression between morphine and mock datasets, we performed pairwise differential expression anal-
ysis on specific cell subpopulations using the SCDE package, which fits individual error models to account for stochastic detection of
lowly expressed genes (Kharchenko et al., 2014). We included all Seurat-generated clusters containing > 10 cells from each of 8 bio-
logical replicates (Mock1-4, Morphine1-4), and that had relatively uniform distribution across all replicates. Only 3 neuronal subtypes
(cholinergic interneurons, D1 MSN_Cxcl14+, and D1 MSN_Pcdh8+) did not meet these criteria. We used default settings with the
exception that we varied themin.detected parameter of the clean.counts function to filter out genes detected in less than 2%of cells.
We included the results of every cluster for all gene with p value < 0.5 in Table S2.
Morphine-activated score
Scorewas generated for each cell of the OL lineage using quadratic programming, as previously described (Treutlein et al., 2016) with
the following modifications. Briefly, we log-transformed transcript counts from FACS-RNaseq data of OLs (average of 3 mock or
3 morphine samples). We used this as mock and morphine reference profiles after filtering out genes not appreciably detected by
Drop-seq of OLs (genes detected in < 5% of cells). The R package QuadProg was used for quadratic programming to assign a
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mock score and a morphine score to each single cell from the OL lineage. The values shown in Figure S4 were calculated by dividing
the morphine score by the sum of the mock score and the morphine score to obtain a scaled morphine-activated score (from 0 to 1).
In situ hybridization
Morphine and mock treatments were performed as described above, except that mock treatment was preceded by a subcutaneous
(s.c.) saline injection (Ctrl/Ctrl), andmorphine treatment was preceded by injection with s.c. saline (Ctrl/Morphine) or naltrexone (NTX/
Morphine). After 4 h, brains were harvested and immediately flash-frozen in OCT (optimal cutting temperature compound) in liquid
nitrogen. We stored frozen tissue blocks at 80C prior to sectioning. Twelve-micron thick coronal sections were cut at 20C and
adhered to positively charged Leica slides (one of each of the three treatment conditions per slide), then stored at 80C. Frozen
tissue sections were washed briefly with 1X PBS and fixed in 3.7%para-formaldehyde for 1 h. Following fixation, slides were washed
twice with 1X PBS and then submerged in 70% ethanol overnight at 4C for permeabilization. RNA FISH was performed according to
the Affymetrix ViewRNA protocol.
Imaging and image analysis
We imaged FISH AND IHC slides on a Zeiss LSM880 II confocal microscope at theWashington University Center for Cellular Imaging
(WUCCI). Image files were processed and analyzed in Fiji/ImageJ (Schindelin et al., 2012) software. RGB channels corresponding to
the two Affymetrix probes and DAPI were split. RNA particles in each channel were then identified in a semi-automated manner by
selecting an intensity threshold above which a spot is considered an RNA particle. Numbers of puncta per cell were quantified from
the left and right anterior commissures, the corpus callosum, and the NAc (n = 3 mice per treatment).
In vitro OL culture
We isolated, expanded, and differentiated OPCs into OLs as previously described (Dincman et al., 2012). Briefly, we dissociated cells
from postnatal day 6 (P6) mouse cortices using the papain-based Neural Tissue Dissociation Kit (Miltenyi) andmechanical trituration,
then enriched for OPCs using magnetic cell sorting (MACS) with anti-PDGFRa-conjugated microbeads and a miniMACS separator.
OPCs were expanded for 3 days, passaged to new plates, then differentiated for 6 days (or maintained in proliferation media and
harvested as OPCs). On the sixth day (D6), cells were mock-treated with media, or treated with a low (0.5 mg/ml) or high (5 mg/ml)
dose of morphine sulfate, then harvested for qRT-PCR at 3 h post-treatment. Values shown in Figure S6 are means from three
biological replicates.
Cnp-Cre/Ribotag RNA isolation
Mock/morphine treatment and dissection was performed as described above, except that the entire striatum, corpus callosum,
or 40 mg of cortex were harvested and transferred to microcentrifuge tubes containing 500 mL polysome lysis buffer. Lysis and
immunoprecipitation were performed as previously described (Sanz et al., 2009). Lysates were applied toMachery Nagel Nucleospin
RNA columns and RNA was purified per the manufacturer’s protocol.
Quantitative real-time PCR
RNA isolated fromCnp-Cre x Ribotagmice or FACS-isolated OLs (see below) was reverse transcribed using qScript cDNA Supermix
from QuantaBio according to the manufacturer’s protocol. cDNA was mixed with Fast SYBR Green master mix from ThermoFisher
and primers to the indicated gene (see Table S4 for primer sequences) in a 96-well plate and quantified using the Quant Studio 3 from
Applied Biosciences (in technical triplicates). Differences in relative gene expression were calculated using the delta delta cTmethod
after normalization to beta-actin.
Immunostaining and FACS of OLs
WTmice were injected with saline (mock) or morphine as described above. Four h later, mice were euthanized and entire brains were
removed, minced with a razor blade, and dissociated with papain solution (400 units of papain in 8 mL total volume). After 50 min
dissociation, suspensions were diluted with EBSS #2 (Saxena et al., 2012), serially passed through 100 mm and 40 mm filters, and
centrifuged at 300g for 5 min. The pellet was resuspended in 35% Percoll solution prepared in EBSS containing 0.1% BSA and
5% trehalose, then centrifuged at 800g for 20 min at 18C. The supernatant containing myelin and cell debris was carefully removed
and the pellet was resuspended in flow cytometry buffer (1% normal mouse serum, 1% normal rat serum, 5% trehalose, 0.1% BSA,
1 mM EDTA in DPBS). Cells were counted using a hemocytometer and 3e6 cells were transferred to a fresh tube, pelleted by brief
centrifugation at 300g, and resuspended in 200 mL flow cytometry buffer containing the following fluorophore-conjugated antibodies
(or isotype controls): GalC-FITC (4 mg; Millipore), PDGFRa-PE (2 mg; BD Biosciences), Mog-Cy5 (4 mg; Millipore; conjugated with
Lightning Link kit from Novus Bio), and CD45-PacBlue (2 mg; BioLegend). Tubes were incubated at 4C with gentle rotation for
30 min, protected from light. Cells were washed twice with and resuspended in flow cytometry buffer (500 mL) and stored on ice
protected from light until sorting (< 30 min). Samples were sorted into flow cytometry buffer using the Sony SY3200 ‘‘Synergy’’
with 100 mm nozzle size at the Siteman Cancer Center Flow Cytometry Core.
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RNA purification, library prep, and sequencing
Immediately following FACS, cells (100K per sample) were centrifuged at 300g for 5 min at 4C, and the supernatant was carefully
removed. The pellet was resuspended in 300 mL Trizol reagent and RNA was purified according to the manufacturer’s protocol.
Sequencing libraries were generated using the SeqPlex RNA Amplification Kit (Sigma) according to the manufacturer’s instructions
and sequenced to a depth of 30 million raw reads per sample (single-end, 50 bp) on the Illumina HiSeq2500.
RNaseq alignment and DE analysis
Reads were mapped to the mouse genome mm10 using STAR. We used htseq to generate gene-count tables for all samples, then
performed differential expression between the 3 replicates each from mock- or morphine-treated mice using DESeq. We first
removed genes whose basemean expression was < 30, leaving 12,000 genes. For Figure 4A, we filtered the genes by adjusted
p value (p-adj) and log2(fold-change) to generate three lists with increasing stringency: ‘‘Top 1000’’ – p-adj < 0.05 and abs[log2FC]
> 0.5; ‘‘Top 500’’ – p-adj < 1e-7 and abs[log2FC] > 0.5; ‘‘Top 200’’ – p-adj < 1e-12 and abs[log2FC] > 1. SCDE false discovery rate
(FDR) was determined by dividing the number of true positives (which were defined as those present in the Top 1000 list) by the total
number of genes at a given SCDE p value cutoff. FDR calculations were iterated over the full range of SCDE p value thresholds.
An empirical FDR of 3.5% corresponded to an SCDE p value cutoff of 0.13.
Pathway analysis of RNaseq data
Pathway analysis was performed using Genomatix GeneRanker software. For single-cell data, we used as input lists: (i) genes
enriched in D1 MSNs of the activated MSN cluster compared to all other D1 MSNs (SCDE p < 0.001; 256 genes), (ii) morphine-regu-
lated genes in OLs (SCDE p < 0.05, abs[log2FC] > 0.4; 69 genes), or (iii) morphine-regulated genes in astrocytes (SCDE p < 0.3; 81
genes). For bulk RNaseq analysis, we used the top 200 morphine-induced (p-adj < 1e-12, log2FC > 1) or the top 148 morphine-
repressed (p-adj < 1e-8, log2FC < 0.5) genes.
QUANTIFICATION AND STATISTICAL ANALYSIS
Single-cell analysis
Error bars in Figures 2B, 4B, and S2 represent the standard deviation among four biological replicates per treatment.
FISH
Quantification in Figures 5 and S5was performed using Fiji/ImageJ software (Schindelin et al., 2012). RGB channels corresponding to
the two Affymetrix probes and DAPI were split. RNA particles in each channel were then identified in a semi-automated manner by
selecting an intensity threshold above which a spot is considered an RNA particle. The number of puncta, their average size, and total
area of signal was calculated for each probe. Cell number was quantified by DAPI signal using the NucleusCounter plugin in ImageJ.
For Figure S5, positive cells were defined as having at least 5 puncta for the designated gene within 1 micron of the nucleus. For
Figure 5, OLs were defined as having at least 2 Mbp puncta within 1 micron of the nucleus. By these criteria, 95% of the cells in
the anterior commissure and corpus callosum and10%of cells in the NAcwere classified asOLs. Error bars represent the standard
deviation among three biological replicates (3 mice per condition) and statistical significance was assessed by paired t test,
two-sided.
qRT-PCR
Differences in relative gene expression were calculated using the delta delta cT method after normalization to beta-actin. Values
shown are the mean plus SEM of three biological replicates (Figure S6) or three replicate plates (Figure S7), with each sample run
in technical triplicate.
DATA AND SOFTWARE AVAILABILITY
The accession number for the raw and processed sequencing data reported in this paper is GEO: GSE118918.
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Figure S1. Quality control of Drop-seq libraries and correlation with previous RNA-seq datasets of the mouse 
nucleus accumbens, Related to Figure 1. (A) Age of mice for each biological replicate. (B) Cumulative read 
distribution for a subset of STAMPS (~500) from the first biological replicate. (C) Read count distribution for Mock1 
and Morphine1. (D-E) Number of Significant STAMPS (D) or median genes and UMIs (E) were ploted for each sample 
as a function of sequencing depth. (F) Our samples (log-transformed gene expression averaged across al single cels) 









































































Cx3cr1Mrc1 DcnLy6c1 Rgs5 Cnp ApodPdgfra
Pdgfra
Gpr17Sst Penk Tubb3Dlx1Hmgb2Ccdc153 Olfm1Aldoc Fyn
Cx3cr1Mrc1 DcnLy6c1 Rgs5 Cnp ApodGpr17Sst Penk Tubb3Dlx1Hmgb2Ccdc153 Olfm1Aldoc Fyn
Cluster Names n (%) CelsA
B
 nGenes (x1000)
0    1    2    3    4    5
0    1    2    3    4    5
Mock
Morphine
Figure S2. Proportions and marker genes of major CNS cel types are unchanged by acute morphine treatment, 
Related to Figure 1. On left, unbiased hierarchical clustering yields highly similar trees. The number (and percentage) of 
cels identified per cluster, number of genes (nGenes), and expression of cel type marker genes are also comparable 
between mock and morphine samples (clusters are color-coordinated as in Figure 1). In the nGenes box-and-whisker 
plots, the vertical line represents the median across al single cels in a given cluster, the box extends from the 25th to 
75th percentile, and the whiskers extend from the minimum to maximum. Those with an open-ended whisker have a max 
























Figure S3. Neuronal subcluster-enriched genes are expressed in the nucleus accumbens, Related to Figure 2. t-SNE 
plots of neuron subclusters were overlaid with single-cel expression of cluster-enriched marker genes, which corelates 
wel with published ISH data (at Bregma +1; Alen Brain Atlas). 
Figure S4. Morphine-activated score for oligodendrocyte subclusters, Related to Figure 4. A morphine-activated 
score was generated for each cel from the OL lineage (see Methods). (left panel) The distribution of scores is ploted for 
cels from each oligodendrocyte subcluster from mock (-) or morphine (+) treated mice. Horizantal lines, box boundaries, 
and eror bars denote median, 25th/75th percentile, and min/max, respectively. (right panel) The fraction of cels from 
each cluster with a non-zero morphine-activated score is ploted. OPC: OL progenitor cel; COP: 












































OLs (D6) - 3 hr after morphine
Figure S6. In vitro OL culture failed to recapitulate morphine-dependent 
changes observed in vivo, Related to Figures 4 and 5. (A) Bright-field 
micrographs of purified OPCs (2 days after isolation and plating) and OLs (D4: 
4 days of diferentiation). Scale bar = 100 µm. (B) qRT-PCR of the indicated 
genes comparing relative expression between OLs (6 days of diferentiation) 
and OPCs. (C) qRT-PCR of the indicated genes folowing a 3-hour treatment of 
D6 OLs with morphine. In (B) and (C), values were normalized to Gapdh, and 
eror bars represent the standard deviation among three biological replicates.


Biological Processes - Protein FoldingMolecular Functions - Unfolded Protein Binding
Pharmacological Substances - Dexamethasone
(Glucocorticoid Receptor Signaling)
Celular Components - Endoplasmic Reticulum
Figure S9. Summary of the most significantly enriched biological pathways and terms among morphine-regulated 
genes in oligodendrocytes, Related to Figures 6 and 7. These terms are significantly enriched as assessed by 
GeneRanker software (see also Table S3). Genes are aranged by their reported subcelular localization and interactions 
and colored by the magnitude of log
2
FC (green – upregulated by morphine; red – downregulated by morphine). 
Dexamethasone p = 5.32e-4; Unfolded Protein Binding p = 1.27e-9; Protein Folding p = 2.43e-9; Endoplasmic 
Reticulum p = 3.5e-4. Adjustped p-values for these terms are < 0.001 for al.
